Agilent Technologies Inc (A)

Healthcare | Medical Diagnostics Research
Latest reporting period: 2026-01-31

Latest Quarter

2026-01-31

Revenue

$1.8B

Net Income

$305M

Operating Margin

19.6%

Free Cash Flow

$1.2B

Debt / Assets

47.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Agilent Technologies Inc (A).
Income Statement (Quarterly) 2026-01-31 2025-10-31 2025-07-31 2025-04-30
Revenue 1,798,000,000 1,861,000,000 1,738,000,000 1,668,000,000
Cost of Revenue 852,000,000 897,000,000 824,000,000 802,000,000
Gross Profit 946,000,000 964,000,000 914,000,000 866,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 476,000,000 428,000,000 417,000,000 454,000,000
Operating Expenses 593,000,000 521,000,000 554,000,000 566,000,000
Operating Income 353,000,000 443,000,000 360,000,000 300,000,000
Interest Expense 25,000,000 27,000,000 28,000,000 29,000,000
Income Before Tax 364,000,000 442,000,000 366,000,000 260,000,000
Income Tax Expense 59,000,000 8,000,000 30,000,000 45,000,000
Net Income 305,000,000 434,000,000 336,000,000 215,000,000
Per Share
EPS 1.08 1.53 1.18 0.75
EPS Diluted 0.00 0.00 0.00 0.00